Search research articles
Contact Us
Filters
Showing results (111-120 of 246) with videos related to
Page
of 25
Sort By:
Clinical and Experimental Rheumatology
|
January 27, 2022
Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines
Marta Novella-Navarro, Fernanda Genre, Borja Hernández-Breijo, et al.
Scientific Reports
|
May 12, 2021
Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, et al.
Rheumatology (Oxford, England)
|
January 4, 2024
Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases
Ana Martínez-Feito, Marta Novella-Navarro, Borja Hernández-Breijo, et al.
Clinical Rheumatology
|
June 25, 2026
Uveitis in spondyloarthritis: clinical patterns and differences between axial and peripheral forms
Elena Miguélez Sánchez, Marina Molinari Pérez, Carolina Tornero Marín, et al.
Therapeutic Advances in Musculoskeletal Disease
|
October 13, 2022
Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
Marta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide, et al.
Human Immunology
|
September 18, 2007
Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility
Alfonso Martínez, Gisela Orozco, Jezabel Varadé, et al.
Arthritis Research & Therapy
|
October 8, 2016
A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis
Silvia Torices, Antonio Julia, Pedro Muñoz, et al.
The Journal of Rheumatology
|
January 15, 2025
Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study
Christopher J Edwards, Gerhard Krönke, Jérôme Avouac, et al.
RMD Open
|
August 18, 2022
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
Charlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, et al.
Reumatologia Clinica
|
August 13, 2018
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis
Jesús Tornero Molina, Alejandro Balsa Criado, Francisco Blanco García, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 246) with videos related to
Sort By:
Page
of 25
Clinical and Experimental Rheumatology
|
January 27, 2022
Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines
Marta Novella-Navarro, Fernanda Genre, Borja Hernández-Breijo, et al.
Scientific Reports
|
May 12, 2021
Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
Cristina Regueiro, Laura Nuño, Ana Triguero-Martinez, et al.
Rheumatology (Oxford, England)
|
January 4, 2024
Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases
Ana Martínez-Feito, Marta Novella-Navarro, Borja Hernández-Breijo, et al.
Clinical Rheumatology
|
June 25, 2026
Uveitis in spondyloarthritis: clinical patterns and differences between axial and peripheral forms
Elena Miguélez Sánchez, Marina Molinari Pérez, Carolina Tornero Marín, et al.
Therapeutic Advances in Musculoskeletal Disease
|
October 13, 2022
Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
Marta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide, et al.
Human Immunology
|
September 18, 2007
Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility
Alfonso Martínez, Gisela Orozco, Jezabel Varadé, et al.
Arthritis Research & Therapy
|
October 8, 2016
A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis
Silvia Torices, Antonio Julia, Pedro Muñoz, et al.
The Journal of Rheumatology
|
January 15, 2025
Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study
Christopher J Edwards, Gerhard Krönke, Jérôme Avouac, et al.
RMD Open
|
August 18, 2022
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
Charlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, et al.
Reumatologia Clinica
|
August 13, 2018
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis
Jesús Tornero Molina, Alejandro Balsa Criado, Francisco Blanco García, et al.
Page
of 25